Ultragenyx Pharmaceutical
RARE
#4473
Rank
ยฃ1.72 B
Marketcap
ยฃ17.91
Share price
-0.17%
Change (1 day)
-45.34%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: ยฃ1.72 Billion

As of January 2026 Ultragenyx Pharmaceutical has a market cap of ยฃ1.72 Billion. This makes Ultragenyx Pharmaceutical the world's 4473th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.72 B-29.45%
2025ยฃ2.44 B-23.34%
2024ยฃ3.19 B3.66%
2023ยฃ3.08 B14.8%
2022ยฃ2.68 B-36.77%
2021ยฃ4.24 B-36.8%
2020ยฃ6.71 B256.65%
2019ยฃ1.88 B8.13%
2018ยฃ1.74 B19.2%
2017ยฃ1.46 B-37.23%
2016ยฃ2.32 B-20.9%
2015ยฃ2.94 B227.02%
2014ยฃ0.90 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

ยฃ1.72 Billion
by Nasdaq info icon info icon
ยฃ1.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
ยฃ8.01 B 363.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ3.30 B 91.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.56 B-67.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
ยฃ0.33 B-80.60%๐Ÿ‡บ๐Ÿ‡ธ USA